From AI Tools to AI Colleagues: How Agentic AI Will Transform the Pharmaceutical Enterprise

Artificial Intelligence has already changed how pharmaceutical companies search, analyse and automate. But the next transformation is far bigger. We are entering the era of Agentic AI, where autonomous AI agents don't just assist people, they execute complex workflows across research, clinical development, manufacturing, regulatory affairs and commercial operations.

This opening keynote explores how leading pharmaceutical organisations are moving beyond AI pilots toward AI-powered enterprises. Through practical examples and emerging industry use cases, attendees will discover where Agentic AI is already creating measurable value, why many initiatives fail to scale, and how governance, trust and human oversight become critical competitive advantages.

Whether you're exploring AI for the first time or scaling enterprise-wide initiatives, this session will provide the strategic framework needed to understand the future of work in pharma, where employees won't simply use AI tools, but lead teams of autonomous AI colleagues.